PULMONARY TRICHOSPORONOSIS

PULMONARY TRICHOSPORONOSIS was reported 23 times

PULMONARY TRICHOSPORONOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Echinocandin Antifungal [EPC] 8 0.0010
1 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 8 0.0006
2 Lipid-based Polyene Antifungal [EPC] 2 0.0002
3 Glycopeptide Antibacterial [EPC] 10 0.0002
4 Tetracycline-class Antibacterial [EPC] 1 0.0001
5 Nitroimidazole Antimicrobial [EPC] 7 0.0001
6 Lipopeptide Antibacterial [EPC] 1 0.0001
7 Recombinant Human Deoxyribonuclease 1 [EPC] 2 0.0001
8 Aminoglycoside Antibacterial [EPC] 4 0.0001
9 Penem Antibacterial [EPC] 3 0.0001
10 Bile Acid [EPC] 2 0.0001
11 Interleukin-6 Receptor Antagonist [EPC] 8 0.0001
12 Polyene Antifungal [EPC] 2 0.0000
13 Human Immunoglobulin G [EPC] 1 0.0000
14 Antimetabolite Immunosuppressant [EPC] 1 0.0000
15 Azole Antifungal [EPC] 5 0.0000
16 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
17 Fluoroquinolone Antibacterial [EPC] 3 0.0000
18 Purine Antimetabolite [EPC] 2 0.0000
19 Alkylating Drug [EPC] 4 0.0000
20 BCL-2 Inhibitor [EPC] 1 0.0000
21 Tetracycline-class Drug [EPC] 1 0.0000
22 Corticosteroid [EPC] 13 0.0000
23 Aminosalicylate [EPC] 1 0.0000
24 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
25 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
26 Osmotic Laxative [EPC] 2 0.0000
27 Microtubule Inhibitor [EPC] 1 0.0000
28 Vitamin C [EPC] 2 0.0000
29 Insulin Analog [EPC] 2 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
34 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
35 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 1 0.0000